Zepbound is the latest weight loss medication to gain approval from the FDA. As with many of the other weight loss medications that have gained FDA approval in recent years, Zepbound is delivered to the body via injection.
Zepbound is an injectable medication that provides the drug Tirzepatide. The same drug is also distributed under the Mounjaro brand name as an FDA-approved treatment for type-2 diabetes.
Zepbound is the latest weight loss medication to gain approval from the FDA. As with many of the other weight loss medications that have gained FDA approval in recent years, Zepbound is delivered to the body via injection.
With obesity levels continuing to rise on a worldwide scale, every time a treatment becomes available, it becomes big news. This is certainly the case with Zepbound. Since the FDA approved its use as an anti-obesity medication on November 8 2023, Zepbound has become a hot topic of conversation, with many media outlets rushing to cover the news of its upcoming release as a prescription weight loss injection in 2024.
However, as with many similar medications, such as Wegovy (Semaglutide) and Saxenda (Liraglutide), Zepbound can present some very undesirable side effects. There are also OTC diet pills that work in a similar way to Zepbound that are safer and cost a fraction of the price.
With an expected price tag of $1,000+ per month, Zepbound is also going to be an expensive weight loss medication to use
As touched upon, weight loss injections like Zepbound (and Ozempic, Wegovy etc) do have issues with side effects, availability and price. Here are the most popular and effective safer alternatives.
PhenQ is a natural weight loss supplement that focuses on weight loss from several different angles, making it a popular choice among individuals looking to reduce their weight. Here's why it might be considered an excellent, safer, and cheaper alternative to prescription weight loss injections like Zepbound:
Clenbutrol can be a great choice for men and women to lose weight but not use injections such as Zepbound.
Zotrim is a dietary supplement designed to help control hunger and promote weight loss. Here's why it might be considered an excellent, safer, and cheaper alternative to prescription weight loss injections like Ozempic:
Zepbound is an injectable medication that provides the drug Tirzepatide. The same drug is also distributed under the Mounjaro brand name as an FDA-approved treatment for type-2 diabetes. It has secondary value as an appetite suppressant so doctors often prescribe Mounjaro "off-label" to patients who are extremely overweight or obese.
The one difference between Zepbound and Mounjaro is Zepbound provides Tirzepatide in a slightly higher dose.
In common with many competing drugs, Tirzepatide is a glucagon-like peptide 1 (GLP-1) receptor agonist. Also called GLP-1 analogs and incretin mimetics, drugs of this type mimic the abilities of the hormone GLP-1, which is released in the gut as a response to the presence of food.
After its release, GLP-1 regulates insulin and glucagon, both of which are responsible for controlling blood glucose levels.
GLP-1 receptor agonists can present a number of side effects. One of them is loss of appetite. Hence Tirzepatide's value as a weight loss drug.
However, Tirzepatide differs from competing drugs such as Semaglutide and Liraglutide because it does not solely function as a GLP-1 receptor agonist. It mimics the activities of a satiety hormone called glucose-dependent insulinotropic polypeptide (GIP) as well.
Although Mounjaro does the same things, it's important to remember its use as weight loss aid is off-label. Zepbound is the only FDA-approved weight loss medication that has the ability to influence both GLP-1 and GIP.
Due to the role GIP plays in hunger suppression, Zepbound could be seen as having greater value than any of the other popular weight loss jabs.
Zepbound is manufactured by Eli Lilly and Company. It's a high-profile pharmaceutical company based in the United States.
Eli Lilly is probably best known for developing the anti-depressant medication Prozac (fluoxetine). However, these days, it gets more attention due to its other creation, Tirzepatide, which gained FDA approval as an anti-diabetic in May 2022. Now, 18 months later, and not unexpectedly, the FDA has approved its use for weight loss.
Zepbound is delivered to the body via once-weekly injections. The needle is inserted just under the skin, never into a muscle or a vein.
Popular injection sites include the belly, and upper thighs. The medication is provided in pre-dosed pens.
There will be six Zepbound dose options:
With this type of medication it's normal to begin with the lowest dose injector pen and then gradually increase the dose each month.
Eli Lilly plans to make Zepbound available in U.S. pharmacies at the start of 2024.
Tirzepatide is also presently under regulatory review for weight management purposes in the United Kingdom, Europe, China, and several other parts of the world.
Eli Lilly says Zepbound will have a list price of $1,059.87 for a 4-week treatment. Depending on their policy details and coverage, some people may be able to get their insurance provider to foot most of the bill.
With appropriate insurance coverage the out-of-pocket expense of using Zepbound may be as low as $25 for a 1-month or 3-month prescription.
Eli Lilly also plans on creating a commercial savings card program that may make the new weight loss medication more accessible. For those who are eligible, the program may bring the cost of using Zepbound down to $550 per month.
However, although this is 50% saving on the list price, that's still $112.50 per injection. Overweight people on tight budgets may struggle to pay this and be forced to seek out cheaper alternatives to use instead.
As with other prescription-only weight loss medications, Zepbound will only be available to adults who are obese (BMI of 30 kg/m2 or greater) or those who are overweight (BMI of 27 kg/m2 or greater) and also have weight-related medical conditions such as high blood pressure, obstructive sleep apnea, or cardiovascular disease.
Those who are eligible for a Zepbound prescription will be expected to make appropriate efforts with diet and exercise.
The eligibility criteria is set by the FDA. However, before they prescribe Zepbound for weight loss, doctors will also need to consider additional factors such as the way Zepbound may interact with existing medications or the additional risks it may present to people who have certain medical conditions such as thyroid problems or pancreatitis.
Although it remains to be seen how the new medication will perform in the wild, data from clinical trials suggest Zepbound may be a useful weight loss tool.
Study data shows obese adults taking Zepbound at the highest dose (15 mg) lost, on average, 48 lbs after 72 weeks of treatment.
The study participants taking the lowest dose (5 mg) lost 34 lbs. Although this is considerably less than the weight losses associated with higher doses, it's still 27 lbs more than the members of the placebo group.
It's also worth noting 1 in 3 of the study participants taking 15 mg per week achieved 58 lb weight losses. This equated to a 35% overall reduction in body weight.
As with most pharmaceutical interventions, Zepbound can cause side effects. The most common side effects experienced by study participants were gastrointestinal issues such as nausea, vomiting, constipation, and abdominal pain.
Injection site reactions were also and issue for around 5% of users, as was fatigue, hair loss, and belching.
Zepbound may also cause more serious side effects including gallbladder problems, kidney failure, pancreatitis, depression, and thoughts of suicide.
Many media outlets neglect to mention these risks but were not going to do that here.
It's also worth noting the Zepbound information sheet that will accompany the new medication, bears a black box warning that relates to the risk of thyroid c-cell tumors. (https://pi.lilly.com/us/zepbound-uspi.pdf)
Zepbound is a weight loss medication that recently gained FDA approval and will shortly become available in U.S. pharmacies. It will only be available via prescription.
Prescription eligibility will be limited to people who are extremely overweight or obese. Other restrictions may also apply depending on individual medical histories and existing medication usage.
Zepbound is an injectable drug that has produced reasonable results during clinical trials. However, with a list price of over $1,000 per month, many people may find Zepbound prohibitively expensive.
The potential side effects and health risks do not work in the medication's favor either. Nevertheless, there is a lot of interest in Zepbound and it's going to be available soon.
Weight loss injections such as Zepbound, Ozempic, or Wegovy are prescription medications that can be used to manage weight, particularly for people with certain health conditions like type 2 diabetes. However, they aren't suitable or necessary for everyone.
Here are ten reasons why you might consider a natural weight loss supplement over Zepbound injections:
Remember, it's important to consult with a healthcare provider before starting any new diet or weight loss supplement regimen. Weight loss supplements, whether natural or prescription, are not a magic solution and should be used in conjunction with a healthy diet and regular exercise.
Disclaimer: The above is a sponsored post, the views expressed are those of the sponsor/author and do not represent the stand and views of Outlook Editorial.